GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Equasens (STU:PHF) » Definitions » Selling and Marketing Expense

Equasens (STU:PHF) Selling and Marketing Expense : €0.0 Mil (TTM As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Equasens Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Equasens's Selling and Marketing Expense for the six months ended in Jun. 2023 was €0.0 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2023 was €0.0 Mil.

Equasens Selling and Marketing Expense Historical Data

The historical data trend for Equasens's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Equasens Selling and Marketing Expense Chart

Equasens Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Equasens Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Equasens Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Equasens Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Equasens's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Equasens (STU:PHF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Equasens (STU:PHF) » Definitions » Selling and Marketing Expense
Comparable Companies
XPAR:CGM XPAR:ABLD XPAR:ALSMA XPAR:ALINS XPAR:ALAMA GEHC VEEV SOLV TSE:2413 ASX:PME HQY RCM DOCS TXG EVH PGNY GDRX CERT PINC TDOC
Traded in Other Exchanges
EQS:France
Address
5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Website
https://www.equasens.com
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) and patients in both primary and secondary care sectors. With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens is developing the healthcare platform and an ecosystem in France and Europe benefiting people by making available its technology services.

Equasens (STU:PHF) Headlines

From GuruFocus

Bulldog Investors Sniffs Out Value in the Pacholder High Yield Fund

By Kyle Ferguson Kyle Ferguson • 04-14-2017